Early detection of ovarian cancer (Q34094731)

31 July 2017

title

Early detection of ovarian cancer (English)

1 reference

31 July 2017

1 reference

Robert C Bast

0 references

Partha M Das

1 reference

31 July 2017

publication date

1 June 2008

1 reference

31 July 2017

published in

Biomarkers in Medicine

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

291-303

1 reference

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Antibody arrays--an emerging tool in cancer proteomics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Recent technical strategies to identify diagnostic biomarkers for ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

28 July 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Multiple biomarker panels for early detection of ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

microRNAs exhibit high frequency genomic alterations in human cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Profiling bladder cancer using targeted antibody arrays

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Potential markers that complement expression of CA125 in epithelial ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Tissue kallikreins: new players in normal and abnormal cell growth?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

A data review and re-assessment of ovarian cancer serum proteomic profiling

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Status of Tumor Markers in Ovarian Cancer Screening

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Osteopontin as a potential diagnostic biomarker for ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Use of proteomic patterns in serum to identify ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Human kallikrein 10: a novel tumor marker for ovarian carcinoma?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Precursor lesions of ovarian epithelial malignancy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Sonographic prediction of malignancy in adnexal masses using an artificial neural network.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Screening for ovarian cancer: a pilot randomised controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Reactivity of a monoclonal antibody with human ovarian carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Multimodal approach to screening for ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

The CA 125 tumour-associated antigen: a review of the literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Quantifying the potential benefit of CA 125 screening for ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Increased serum levels of macrophage colony-stimulating factor in ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Evaluation of adnexal masses with transvaginal color ultrasound.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Unifocal origin of advanced human epithelial ovarian cancers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Ovarian cancer: can we make the clinical diagnosis earlier?

28 July 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

p53 protein expression in putative precursor lesions of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Identification of genes associated with ovarian cancer metastasis using microarray expression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Early detection of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Comparison of conventional color Doppler imaging and power doppler imaging for the diagnosis of ovarian cancer: results of a European study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Three-dimensional ultrasound and power doppler improve the diagnosis of ovarian lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Lysophospholipids activate ovarian and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.291

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930760

Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma

28 October 2018

1 reference

12 December 2020

Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer

1 reference

12 December 2020

Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients

1 reference

12 December 2020

Screening for ovarian cancer

1 reference

12 December 2020

New monoclonal antibodies identify the glycoprotein carrying the CA 125 epitope

1 reference

12 December 2020

Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer

1 reference

12 December 2020

Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum

1 reference

12 December 2020

1 reference

12 December 2020

Blood flow in benign ovarian tumors and normal ovaries during the follicular phase

1 reference

12 December 2020

Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction

1 reference

12 December 2020

Conventional and color Doppler transvaginal sonography of pelvic masses: a comparison of relative histologic specificities

1 reference

12 December 2020

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

1 reference

12 December 2020

Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses

1 reference

12 December 2020

Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system

1 reference

12 December 2020

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

1 reference

12 December 2020

Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors

1 reference

12 December 2020

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

12 December 2020

Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer

1 reference

12 December 2020

Pattern recognition of pelvic masses by gray-scale ultrasound imaging: the contribution of Doppler ultrasound

1 reference

12 December 2020

Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer

1 reference

12 December 2020

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

1 reference

12 December 2020

OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures

1 reference

12 December 2020

Color Doppler sonography of ovarian masses: a multiparameter analysis

1 reference

12 December 2020

Identifiers

DOI

10.2217/17520363.2.3.291

1 reference

31 July 2017

1 reference

31 July 2017

1 reference